Dermochelys coriacea isolate rDerCor1 chromosome 26, rDerCor1.pri.v4, whole genome shotgun sequence.
Dermochelys coriacea (leatherback sea turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Americhelydia; Chelonioidea; Dermochelyidae; Dermochelys.
REFSEQ INFORMATION: The reference sequence is identical to\nCM019960.2.\nAssembly name: rDerCor1.pri.v4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the G10K on 2021/08/25. The\noriginal whole-genome shotgun project has the accession\nWSPL00000000.4.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: G10K\nAssembly Date :: 24-MAY-2021\nAssembly Method :: FALCON DNANexus v. 1.9.0; FALCON-Unzip\n DNANexus v. 1.0.6; purge_dups v. v1;\n scaff10x v. 4.1.0; Bionano Solve DLS v.\n 3.2.1; Salsa HiC v. 2.2.2; Arrow\n smrtanalysis Pacbio polishing & gap\n filling v. 6.0.0.47841; longranger align\n v. 2.2.2; freebayes Illumina polishing v.\n 1.3.1; gEVAL manual curation v.\n 2021-05-24; VGP assembly pipeline\n individual v. 1.6\nAssembly Name :: rDerCor1.pri.v4\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 63.68x\nSequencing Technology :: PacBio Sequel I CLR; llumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Dermochelys coriacea Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC122457553, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122457553, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 26-like, transcript variant X1
zinc finger protein 26-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 26-like, transcript variant X5
zinc finger protein 26-like, transcript variant X4
zinc finger protein 26-like, transcript variant X2
zinc finger protein 26-like, transcript variant X3
zinc finger protein 26-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger protein 26-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DNA polymerase beta, transcript variant X2
DNA polymerase beta, transcript variant X1
DNA polymerase beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
dickkopf WNT signaling pathway inhibitor 4, transcript variant X1
dickkopf WNT signaling pathway inhibitor 4, transcript variant X3
dickkopf WNT signaling pathway inhibitor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
voltage dependent anion channel 3, transcript variant X3
voltage dependent anion channel 3, transcript variant X5
voltage dependent anion channel 3, transcript variant X4
voltage-dependent anion-selective channel protein 3 isoform X4
voltage dependent anion channel 3, transcript variant X2
voltage dependent anion channel 3, transcript variant X1
voltage-dependent anion-selective channel protein 3 isoform X1
voltage-dependent anion-selective channel protein 3 isoform X2
voltage-dependent anion-selective channel protein 3 isoform X3
voltage-dependent anion-selective channel protein 3 isoform X5
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X3
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X2
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X1
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X3
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1
plasminogen activator, tissue type, transcript variant X1
plasminogen activator, tissue type, transcript variant X2
plasminogen activator, tissue type, transcript variant X3
adaptor related protein complex 3 subunit mu 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
glycerol-3-phosphate acyltransferase 4, transcript variant X3
glycerol-3-phosphate acyltransferase 4, transcript variant X4
glycerol-3-phosphate acyltransferase 4, transcript variant X2
glycerol-3-phosphate acyltransferase 4, transcript variant X1
uncharacterized PE-PGRS family protein PE_PGRS46-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
protein phosphatase 1 regulatory subunit 3C-B-like, transcript variant X2
protein phosphatase 1 regulatory subunit 3C-B-like, transcript variant X1
protein phosphatase 1 regulatory subunit 3C-B-like isoform X2
protein phosphatase 1 regulatory subunit 3C-B-like isoform X1
DNA replication complex GINS protein SLD5
secreted frizzled related protein 1, transcript variant X1
secreted frizzled related protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
secreted frizzled-related protein 1 isoform X2
secreted frizzled-related protein 1 isoform X1
zinc finger matrin-type 4, transcript variant X8
zinc finger matrin-type 4, transcript variant X10
zinc finger matrin-type 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger matrin-type 4, transcript variant X2
zinc finger matrin-type 4, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger matrin-type 4, transcript variant X13
zinc finger matrin-type protein 4 isoform X4
zinc finger matrin-type protein 4 isoform X1
zinc finger matrin-type protein 4 isoform X5
zinc finger matrin-type protein 4 isoform X2
zinc finger matrin-type protein 4 isoform X8
zinc finger matrin-type 4, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger matrin-type 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger matrin-type 4, transcript variant X3
zinc finger matrin-type 4, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger matrin-type 4, transcript variant X15
zinc finger matrin-type 4, transcript variant X14
zinc finger matrin-type 4, transcript variant X7
zinc finger matrin-type 4, transcript variant X5
zinc finger matrin-type 4, transcript variant X6
zinc finger matrin-type protein 4 isoform X9
zinc finger matrin-type protein 4 isoform X6
zinc finger matrin-type protein 4 isoform X3
zinc finger matrin-type protein 4 isoform X7
uncharacterized LOC122457560, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122457560, transcript variant X2
transcriptional and immune response regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
indoleamine 2,3-dioxygenase 2, transcript variant X2
indoleamine 2,3-dioxygenase 2, transcript variant X1
indoleamine 2,3-dioxygenase 2 isoform X2
indoleamine 2,3-dioxygenase 2 isoform X1
indoleamine 2,3-dioxygenase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
indoleamine 2,3-dioxygenase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
indoleamine 2,3-dioxygenase 1 isoform X2
indoleamine 2,3-dioxygenase 1 isoform X1
uncharacterized LOC119848800, transcript variant X2
uncharacterized LOC119848800, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 32-like isoform X2
disintegrin and metalloproteinase domain-containing protein 32-like isoform X1
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 32-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 4 codons; substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: disintegrin and metalloproteinase domain-containing protein 9
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine protease HTRA4
pleckstrin homology domain containing A2, transcript variant X2
pleckstrin homology domain containing A2, transcript variant X1
pleckstrin homology domain-containing family A member 2 isoform X2
pleckstrin homology domain-containing family A member 2 isoform X1
transforming acidic coiled-coil containing protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 10 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 long SRA reads, 6 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transforming acidic coiled-coil-containing protein 1 isoform X2
transforming acidic coiled-coil-containing protein 1 isoform X6
transforming acidic coiled-coil-containing protein 1 isoform X3
transforming acidic coiled-coil-containing protein 1 isoform X5
transforming acidic coiled-coil-containing protein 1 isoform X1
transforming acidic coiled-coil-containing protein 1 isoform X4
transforming acidic coiled-coil-containing protein 1 isoform X8
transforming acidic coiled-coil-containing protein 1 isoform X7
fibroblast growth factor receptor 1, transcript variant X5
fibroblast growth factor receptor 1, transcript variant X6
fibroblast growth factor receptor 1, transcript variant X8
fibroblast growth factor receptor 1, transcript variant X9
fibroblast growth factor receptor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibroblast growth factor receptor 1, transcript variant X1
fibroblast growth factor receptor 1, transcript variant X2
fibroblast growth factor receptor 1, transcript variant X3
fibroblast growth factor receptor 1, transcript variant X7
fibroblast growth factor receptor 1 isoform X3
fibroblast growth factor receptor 1 isoform X4
fibroblast growth factor receptor 1 isoform X1
fibroblast growth factor receptor 1 isoform X2
fibroblast growth factor receptor 1 isoform X5
fibroblast growth factor receptor 1 isoform X7
fibroblast growth factor receptor 1 isoform X6
fibroblast growth factor receptor 1 isoform X8
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X1
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X2
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X3
LETM1 domain-containing protein LETM2, mitochondrial
nuclear receptor binding SET domain protein 3, transcript variant X2
nuclear receptor binding SET domain protein 3, transcript variant X8
nuclear receptor binding SET domain protein 3, transcript variant X4
nuclear receptor binding SET domain protein 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
nuclear receptor binding SET domain protein 3, transcript variant X1
nuclear receptor binding SET domain protein 3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
nuclear receptor binding SET domain protein 3, transcript variant X5
nuclear receptor binding SET domain protein 3, transcript variant X6
nuclear receptor binding SET domain protein 3, transcript variant X9
nuclear receptor binding SET domain protein 3, transcript variant X7
nuclear receptor binding SET domain protein 3, transcript variant X3
histone-lysine N-methyltransferase NSD3 isoform X1
histone-lysine N-methyltransferase NSD3 isoform X2
histone-lysine N-methyltransferase NSD3 isoform X3
histone-lysine N-methyltransferase NSD3 isoform X4
histone-lysine N-methyltransferase NSD3 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phospholipid phosphatase 5, transcript variant X4
phospholipid phosphatase 5, transcript variant X3
phospholipid phosphatase 5, transcript variant X1
phospholipid phosphatase 5, transcript variant X2
phospholipid phosphatase 5, transcript variant X5
DDHD domain containing 2, transcript variant X18
DDHD domain containing 2, transcript variant X12
DDHD domain containing 2, transcript variant X9
DDHD domain containing 2, transcript variant X10
DDHD domain containing 2, transcript variant X3
DDHD domain containing 2, transcript variant X1
DDHD domain containing 2, transcript variant X15
DDHD domain containing 2, transcript variant X13
DDHD domain containing 2, transcript variant X16
DDHD domain containing 2, transcript variant X14
DDHD domain containing 2, transcript variant X6
DDHD domain containing 2, transcript variant X2
DDHD domain containing 2, transcript variant X11
DDHD domain containing 2, transcript variant X8
DDHD domain containing 2, transcript variant X7
DDHD domain containing 2, transcript variant X4
DDHD domain containing 2, transcript variant X5
DDHD domain containing 2, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
BAG cochaperone 4, transcript variant X3
BAG cochaperone 4, transcript variant X2
BAG cochaperone 4, transcript variant X1
BAG family molecular chaperone regulator 4 isoform X3
BAG family molecular chaperone regulator 4 isoform X2
BAG family molecular chaperone regulator 4 isoform X1
zinc finger and SCAN domain-containing protein 12-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 83% coverage of the annotated genomic feature by RNAseq alignments
LSM1 homolog, mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm1
G protein-coupled receptor kinase 5-like, transcript variant X2
G protein-coupled receptor kinase 5-like, transcript variant X1
G protein-coupled receptor kinase 5-like, transcript variant X3
G protein-coupled receptor kinase 5-like isoform X1
G protein-coupled receptor kinase 5-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
G protein-coupled receptor kinase 5-like, transcript variant X4
G protein-coupled receptor kinase 5-like isoform X3
steroidogenic acute regulatory protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
steroidogenic acute regulatory protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
steroidogenic acute regulatory protein, mitochondrial
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X3
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X2
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X1
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X4
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X3
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X2
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4E-binding protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 32 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adrenoceptor beta 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adrenoceptor beta 3, transcript variant X1
nucleoplasmin-like, transcript variant X3
nucleoplasmin-like, transcript variant X2
nucleoplasmin-like, transcript variant X1
glutamic-oxaloacetic transaminase 1 like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
putative aspartate aminotransferase, cytoplasmic 2
prolactin-releasing peptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAB11 family interacting protein 1, transcript variant X2
RAB11 family interacting protein 1, transcript variant X1
rab11 family-interacting protein 1 isoform X1
rab11 family-interacting protein 1 isoform X2
BRF2 RNA polymerase III transcription initiation factor subunit, transcript variant X1
BRF2 RNA polymerase III transcription initiation factor subunit, transcript variant X2
BRF2 RNA polymerase III transcription initiation factor subunit, transcript variant X3
transcription factor IIIB 50 kDa subunit
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: adhesion G protein-coupled receptor A2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: pyridoxal phosphate homeostasis protein
ER lipid raft associated 2, transcript variant X3
ER lipid raft associated 2, transcript variant X1
ER lipid raft associated 2, transcript variant X4
ER lipid raft associated 2, transcript variant X2
zinc finger protein 703, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 703, transcript variant X2
potassium calcium-activated channel subfamily U member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 3% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122457565, transcript variant X1
uncharacterized LOC122457565, transcript variant X2
unc-5 netrin receptor D, transcript variant X4
unc-5 netrin receptor D, transcript variant X7
unc-5 netrin receptor D, transcript variant X3
unc-5 netrin receptor D, transcript variant X1
unc-5 netrin receptor D, transcript variant X6
unc-5 netrin receptor D, transcript variant X5
unc-5 netrin receptor D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC119848789, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC119848789, transcript variant X3
uncharacterized LOC119848789, transcript variant X2
dual specificity phosphatase 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 22 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
dual specificity phosphatase 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ring finger protein 122, transcript variant X1
ring finger protein 122, transcript variant X2
ring finger protein 122, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: chromaffin granule amine transporter
ATPase H+ transporting V1 subunit B2, transcript variant X1
ATPase H+ transporting V1 subunit B2, transcript variant X2
V-type proton ATPase subunit B, brain isoform isoform X1
V-type proton ATPase subunit B, brain isoform isoform X2
uncharacterized LOC122457532, transcript variant X2
uncharacterized LOC122457532, transcript variant X1
uncharacterized LOC122457532, transcript variant X3
uncharacterized LOC122457532, transcript variant X4
uncharacterized LOC122457532, transcript variant X5
leucine zipper tumor suppressor 1, transcript variant X2
leucine zipper tumor suppressor 1, transcript variant X3
leucine zipper tumor suppressor 1, transcript variant X5
leucine zipper tumor suppressor 1, transcript variant X4
leucine zipper tumor suppressor 1, transcript variant X1
leucine zipper putative tumor suppressor 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC122457578, transcript variant X2
uncharacterized LOC122457578, transcript variant X1
polysaccharide biosynthesis domain containing 1, transcript variant X2
polysaccharide biosynthesis domain containing 1, transcript variant X1
nucleophosmin/nucleoplasmin 2, transcript variant X4
nucleophosmin/nucleoplasmin 2, transcript variant X5
nucleophosmin/nucleoplasmin 2, transcript variant X1
nucleophosmin/nucleoplasmin 2, transcript variant X3
nucleophosmin/nucleoplasmin 2, transcript variant X2
dematin actin binding protein, transcript variant X3
dematin actin binding protein, transcript variant X6
dematin actin binding protein, transcript variant X25
dematin actin binding protein, transcript variant X7
dematin actin binding protein, transcript variant X15
dematin actin binding protein, transcript variant X20
dematin actin binding protein, transcript variant X14
dematin actin binding protein, transcript variant X21
dematin actin binding protein, transcript variant X8
dematin actin binding protein, transcript variant X16
dematin actin binding protein, transcript variant X9
dematin actin binding protein, transcript variant X22
dematin actin binding protein, transcript variant X17
dematin actin binding protein, transcript variant X2
dematin actin binding protein, transcript variant X4
dematin actin binding protein, transcript variant X13
dematin actin binding protein, transcript variant X5
dematin actin binding protein, transcript variant X12
dematin actin binding protein, transcript variant X1
dematin actin binding protein, transcript variant X11
dematin actin binding protein, transcript variant X19
dematin actin binding protein, transcript variant X24
dematin actin binding protein, transcript variant X10
dematin actin binding protein, transcript variant X18
dematin actin binding protein, transcript variant X23
actin filament-associated protein 1-like 2, transcript variant X1
actin filament-associated protein 1-like 2, transcript variant X2
actin filament-associated protein 1-like 2 isoform X1
actin filament-associated protein 1-like 2 isoform X2
actin filament-associated protein 1-like 2, transcript variant X3
actin filament-associated protein 1-like isoform X3
FHF complex subunit HOOK interacting protein 2B, transcript variant X2
FHF complex subunit HOOK interacting protein 2B, transcript variant X1
FHF complex subunit HOOK interacting protein 2B, transcript variant X10
FHF complex subunit HOOK interacting protein 2B, transcript variant X6
FHF complex subunit HOOK interacting protein 2B, transcript variant X9
FHF complex subunit HOOK interacting protein 2B, transcript variant X4
FHF complex subunit HOOK interacting protein 2B, transcript variant X7
FHF complex subunit HOOK interacting protein 2B, transcript variant X11
FHF complex subunit HOOK interacting protein 2B, transcript variant X3
FHF complex subunit HOOK interacting protein 2B, transcript variant X5
FHF complex subunit HOOK interacting protein 2B, transcript variant X8
FHF complex subunit HOOK interacting protein 2B isoform X1
FHF complex subunit HOOK interacting protein 2B isoform X5
FHF complex subunit HOOK interacting protein 2B isoform X8
FHF complex subunit HOOK interacting protein 2B isoform X3
FHF complex subunit HOOK interacting protein 2B isoform X6
FHF complex subunit HOOK interacting protein 2B isoform X10
FHF complex subunit HOOK interacting protein 2B isoform X2
FHF complex subunit HOOK interacting protein 2B isoform X4
FHF complex subunit HOOK interacting protein 2B isoform X7
FHF complex subunit HOOK interacting protein 2B isoform X9
nudix hydrolase 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
nudix hydrolase 18, transcript variant X3
nudix hydrolase 18, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
nudix hydrolase 18, transcript variant X5
nudix hydrolase 18, transcript variant X4
nudix hydrolase 18, transcript variant X9
nudix hydrolase 18, transcript variant X8
nudix hydrolase 18, transcript variant X1
nudix hydrolase 18, transcript variant X6
nudix hydrolase 18, transcript variant X10
8-oxo-dGDP phosphatase NUDT18 isoform X2
8-oxo-dGDP phosphatase NUDT18 isoform X1
8-oxo-dGDP phosphatase NUDT18 isoform X4
8-oxo-dGDP phosphatase NUDT18 isoform X3
8-oxo-dGDP phosphatase NUDT18 isoform X5
HR lysine demethylase and nuclear receptor corepressor
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LOW QUALITY PROTEIN: lysine-specific demethylase hairless
leucine rich repeat LGI family member 3, transcript variant X4
leucine rich repeat LGI family member 3, transcript variant X3
leucine rich repeat LGI family member 3, transcript variant X2
leucine rich repeat LGI family member 3, transcript variant X1
leucine-rich repeat LGI family member 3 isoform X2
leucine-rich repeat LGI family member 3 isoform X1
leucine-rich repeat LGI family member 3 isoform X3
pulmonary surfactant-associated protein C, transcript variant X1
pulmonary surfactant-associated protein C, transcript variant X3
pulmonary surfactant-associated protein C, transcript variant X4
pulmonary surfactant-associated protein C, transcript variant X2
pulmonary surfactant-associated protein C
pulmonary surfactant-associated protein C-like
uncharacterized LOC119848709, transcript variant X1
uncharacterized LOC119848709, transcript variant X2
collagen alpha-6(VI) chain-like, transcript variant X4
collagen alpha-6(VI) chain-like, transcript variant X2
collagen alpha-6(VI) chain-like, transcript variant X3
collagen alpha-6(VI) chain-like, transcript variant X1
collagen alpha-6(VI) chain-like isoform X4
collagen alpha-6(VI) chain-like isoform X2
collagen alpha-6(VI) chain-like isoform X3
collagen alpha-6(VI) chain-like isoform X1
collagen alpha-6(VI) chain-like, transcript variant X5
collagen alpha-6(VI) chain-like isoform X5
bone morphogenetic protein 1, transcript variant X3
bone morphogenetic protein 1, transcript variant X4
bone morphogenetic protein 1, transcript variant X6
bone morphogenetic protein 1, transcript variant X2
bone morphogenetic protein 1, transcript variant X5
bone morphogenetic protein 1, transcript variant X1
phytanoyl-CoA 2-hydroxylase interacting protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 long SRA reads, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phytanoyl-CoA hydroxylase-interacting protein
DNA-directed RNA polymerase III subunit RPC4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
uncharacterized LOC122457543, transcript variant X2
uncharacterized LOC122457543, transcript variant X1
piwi like RNA-mediated gene silencing 2, transcript variant X5
piwi like RNA-mediated gene silencing 2, transcript variant X4
piwi like RNA-mediated gene silencing 2, transcript variant X3
piwi like RNA-mediated gene silencing 2, transcript variant X1
piwi like RNA-mediated gene silencing 2, transcript variant X7
piwi like RNA-mediated gene silencing 2, transcript variant X6
piwi like RNA-mediated gene silencing 2, transcript variant X9
piwi like RNA-mediated gene silencing 2, transcript variant X10
piwi like RNA-mediated gene silencing 2, transcript variant X2
piwi like RNA-mediated gene silencing 2, transcript variant X8
piwi like RNA-mediated gene silencing 2, transcript variant X11
piwi like RNA-mediated gene silencing 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 39 member 14, transcript variant X1
solute carrier family 39 member 14, transcript variant X3
solute carrier family 39 member 14, transcript variant X2
protein phosphatase 3 catalytic subunit gamma, transcript variant X6
protein phosphatase 3 catalytic subunit gamma, transcript variant X1
protein phosphatase 3 catalytic subunit gamma, transcript variant X4
protein phosphatase 3 catalytic subunit gamma, transcript variant X3
protein phosphatase 3 catalytic subunit gamma, transcript variant X2
protein phosphatase 3 catalytic subunit gamma, transcript variant X5
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X5
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X6
sorbin and SH3 domain containing 3, transcript variant X7
sorbin and SH3 domain containing 3, transcript variant X9
sorbin and SH3 domain containing 3, transcript variant X4
sorbin and SH3 domain containing 3, transcript variant X8
sorbin and SH3 domain containing 3, transcript variant X6
sorbin and SH3 domain containing 3, transcript variant X3
sorbin and SH3 domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sorbin and SH3 domain containing 3, transcript variant X1
sorbin and SH3 domain containing 3, transcript variant X5
PDZ and LIM domain 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 long SRA reads, 14 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
PDZ and LIM domain 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 long SRA reads, 14 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
cell cycle and apoptosis regulator 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
cell cycle and apoptosis regulator 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
cell cycle and apoptosis regulator protein 2 isoform X1
cell cycle and apoptosis regulator protein 2 isoform X2
bridging integrator 3, transcript variant X2
bridging integrator 3, transcript variant X1
bridging integrator 3, transcript variant X3
early growth response 3, transcript variant X1
early growth response 3, transcript variant X2
early growth response protein 3 isoform X1
early growth response protein 3 isoform X2
phosphatidylethanolamine binding protein 4, transcript variant X2
phosphatidylethanolamine binding protein 4, transcript variant X1
phosphatidylethanolamine binding protein 4, transcript variant X3
phosphatidylethanolamine binding protein 4, transcript variant X5
phosphatidylethanolamine binding protein 4, transcript variant X4
phosphatidylethanolamine-binding protein 4 isoform X1
phosphatidylethanolamine-binding protein 4 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: rho-related BTB domain-containing protein 2
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X7
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X6
tumor necrosis factor receptor superfamily member 10D-like isoform X7
tumor necrosis factor receptor superfamily member 10D-like isoform X6
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X4
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X3
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X2
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X5
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X1
tumor necrosis factor receptor superfamily member 10A-like isoform X4
tumor necrosis factor receptor superfamily member 10A-like isoform X2
tumor necrosis factor receptor superfamily member 10A-like isoform X3
tumor necrosis factor receptor superfamily member 10A-like isoform X5
tumor necrosis factor receptor superfamily member 10A-like isoform X1
charged multivesicular body protein 7, transcript variant X5
charged multivesicular body protein 7 isoform X5
charged multivesicular body protein 7, transcript variant X2
charged multivesicular body protein 7, transcript variant X1
charged multivesicular body protein 7, transcript variant X3
charged multivesicular body protein 7, transcript variant X4
charged multivesicular body protein 7 isoform X2
charged multivesicular body protein 7 isoform X1
charged multivesicular body protein 7 isoform X4
charged multivesicular body protein 7 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 30 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
R3H and coiled-coil domain-containing protein 1
lysyl oxidase like 2, transcript variant X4
lysyl oxidase like 2, transcript variant X1
lysyl oxidase like 2, transcript variant X7
lysyl oxidase like 2, transcript variant X3
lysyl oxidase like 2, transcript variant X6
lysyl oxidase like 2, transcript variant X5
lysyl oxidase like 2, transcript variant X2
lysyl oxidase like 2, transcript variant X8
lysyl oxidase like 2, transcript variant X10
lysyl oxidase like 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 4 isoform X2
ectonucleoside triphosphate diphosphohydrolase 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
solute carrier family 25 member 37, transcript variant X1
solute carrier family 25 member 37, transcript variant X2
solute carrier family 25 member 37, transcript variant X3
uncharacterized LOC119848758, transcript variant X1
uncharacterized LOC119848758, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122457525, transcript variant X1
uncharacterized LOC122457525, transcript variant X2
zinc metalloproteinase-disintegrin-like NaMP, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 386 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc metalloproteinase-disintegrin-like NaMP, transcript variant X5
zinc metalloproteinase-disintegrin-like NaMP, transcript variant X1
zinc metalloproteinase-disintegrin-like NaMP, transcript variant X3
zinc metalloproteinase-disintegrin-like NaMP, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 394 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
zinc metalloproteinase-disintegrin-like NaMP, transcript variant X2
zinc metalloproteinase-disintegrin-like NaMP isoform X1
zinc metalloproteinase-disintegrin-like NaMP isoform X3
zinc metalloproteinase-disintegrin-like NaMP isoform X4
zinc metalloproteinase-disintegrin-like NaMP isoform X2
uncharacterized LOC119848785, transcript variant X2
uncharacterized LOC119848785, transcript variant X3
uncharacterized LOC119848785, transcript variant X1
dedicator of cytokinesis 5, transcript variant X1
dedicator of cytokinesis 5, transcript variant X2
dedicator of cytokinesis 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dedicator of cytokinesis protein 5 isoform X1
dedicator of cytokinesis protein 5 isoform X2
potassium channel tetramerization domain containing 9
cell division cycle associated 2, transcript variant X10
cell division cycle associated 2, transcript variant X9
cell division cycle associated 2, transcript variant X13
cell division cycle associated 2, transcript variant X12
cell division cycle associated 2, transcript variant X7
cell division cycle associated 2, transcript variant X14
cell division cycle associated 2, transcript variant X6
cell division cycle associated 2, transcript variant X1
cell division cycle associated 2, transcript variant X11
cell division cycle associated 2, transcript variant X4
cell division cycle associated 2, transcript variant X2
cell division cycle associated 2, transcript variant X3
cell division cycle associated 2, transcript variant X8
cell division cycle associated 2, transcript variant X5
cell division cycle associated 2, transcript variant X15
cell division cycle-associated protein 2 isoform X1
cell division cycle-associated protein 2 isoform X2
LOW QUALITY PROTEIN: transcription factor COE2
protein phosphatase 2 regulatory subunit Balpha
LOW QUALITY PROTEIN: serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform
BCL2 interacting protein 3 like, transcript variant X2
BCL2 interacting protein 3 like, transcript variant X1
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like isoform X1
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like isoform X2
dihydropyrimidinase like 2, transcript variant X5
dihydropyrimidinase like 2, transcript variant X6
dihydropyrimidinase like 2, transcript variant X2
dihydropyrimidinase like 2, transcript variant X7
dihydropyrimidinase like 2, transcript variant X4
dihydropyrimidinase like 2, transcript variant X1
dihydropyrimidinase like 2, transcript variant X3
dihydropyrimidinase-related protein 2 isoform X1
dihydropyrimidinase-related protein 2 isoform X2
dihydropyrimidinase like 2, transcript variant X10
dihydropyrimidinase like 2, transcript variant X9
dihydropyrimidinase-related protein 2 isoform X4
dihydropyrimidinase-related protein 2 isoform X5
dihydropyrimidinase like 2, transcript variant X8
dihydropyrimidinase-related protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC119848734, transcript variant X2
uncharacterized LOC119848734, transcript variant X1
leucine rich repeat transmembrane neuronal 4, transcript variant X3
leucine rich repeat transmembrane neuronal 4, transcript variant X5
leucine rich repeat transmembrane neuronal 4, transcript variant X2
leucine rich repeat transmembrane neuronal 4, transcript variant X8
leucine rich repeat transmembrane neuronal 4, transcript variant X4
leucine rich repeat transmembrane neuronal 4, transcript variant X6
leucine rich repeat transmembrane neuronal 4, transcript variant X7
leucine rich repeat transmembrane neuronal 4, transcript variant X1
leucine-rich repeat transmembrane neuronal protein 4 isoform X1
leucine rich repeat transmembrane neuronal 4, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 11 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine rich repeat transmembrane neuronal 4, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat transmembrane neuronal protein 4 isoform X2
leucine-rich repeat transmembrane neuronal protein 4 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: major prion protein homolog
prion like protein doppel, transcript variant X1
prion like protein doppel, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
prion like protein doppel, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC119848657, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 701 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC119848657, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 701 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC119848657, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: solute carrier family 23 member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
transmembrane protein 230, transcript variant X3
transmembrane protein 230, transcript variant X1
transmembrane protein 230, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: phosphatidate cytidylyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Rho GTPase activating protein 25, transcript variant X1
rho GTPase-activating protein 25 isoform X1
Rho GTPase activating protein 25, transcript variant X2
rho GTPase-activating protein 25 isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 45% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
ANTXR cell adhesion molecule 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ANTXR cell adhesion molecule 1, transcript variant X1
ANTXR cell adhesion molecule 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ANTXR cell adhesion molecule 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamine--fructose-6-phosphate transaminase 1, transcript variant X2
glutamine--fructose-6-phosphate transaminase 1, transcript variant X1
glutamine--fructose-6-phosphate transaminase 1, transcript variant X4
glutamine--fructose-6-phosphate transaminase 1, transcript variant X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
NFU1 iron-sulfur cluster scaffold, transcript variant X7
NFU1 iron-sulfur cluster scaffold, transcript variant X8
NFU1 iron-sulfur cluster scaffold, transcript variant X6
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X7
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X6
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X8
NFU1 iron-sulfur cluster scaffold, transcript variant X3
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X3
NFU1 iron-sulfur cluster scaffold, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
NFU1 iron-sulfur cluster scaffold, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
NFU1 iron-sulfur cluster scaffold, transcript variant X4
NFU1 iron-sulfur cluster scaffold, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X2
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X4
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial isoform X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: AP2-associated protein kinase 1
germ cell-less 1, spermatogenesis associated
LOW QUALITY PROTEIN: germ cell-less protein-like 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
pyroglutamylated RF-amide peptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
family with sequence similarity 136 member A
small nuclear ribonucleoprotein polypeptide G
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: prenylcysteine oxidase 1
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X1
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X8
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X3
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X4
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X2
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X6
TIA1 cytotoxic granule associated RNA binding protein, transcript variant X7
chromosome 26 C2orf42 homolog, transcript variant X3
chromosome 26 C2orf42 homolog, transcript variant X2
chromosome 26 C2orf42 homolog, transcript variant X1
uncharacterized protein C2orf42 homolog isoform X1
uncharacterized protein C2orf42 homolog isoform X2
1,5-anhydro-D-fructose reductase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
1,5-anhydro-D-fructose reductase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 37 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
1,5-anhydro-D-fructose reductase-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
1,5-anhydro-D-fructose reductase-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
1,5-anhydro-D-fructose reductase-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
1,5-anhydro-D-fructose reductase-like, transcript variant X9
1,5-anhydro-D-fructose reductase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
1,5-anhydro-D-fructose reductase-like, transcript variant X7
1,5-anhydro-D-fructose reductase-like, transcript variant X5
1,5-anhydro-D-fructose reductase-like, transcript variant X6
1,5-anhydro-D-fructose reductase-like, transcript variant X2
1,5-anhydro-D-fructose reductase-like isoform X7
1,5-anhydro-D-fructose reductase-like isoform X6
1,5-anhydro-D-fructose reductase-like isoform X9
1,5-anhydro-D-fructose reductase-like isoform X8
1,5-anhydro-D-fructose reductase-like isoform X5
1,5-anhydro-D-fructose reductase-like isoform X3
1,5-anhydro-D-fructose reductase-like isoform X4
1,5-anhydro-D-fructose reductase-like isoform X2
1,5-anhydro-D-fructose reductase-like isoform X1
low molecular weight neuronal intermediate filament-like
MAX dimerization protein 1, transcript variant X2
MAX dimerization protein 1, transcript variant X1
small nuclear ribonucleoprotein U4/U6.U5 subunit 27
U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein
folliculogenesis specific bHLH transcription factor, transcript variant X6
folliculogenesis specific bHLH transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
folliculogenesis specific bHLH transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
folliculogenesis specific bHLH transcription factor, transcript variant X5
folliculogenesis specific bHLH transcription factor, transcript variant X3
folliculogenesis specific bHLH transcription factor, transcript variant X4
uncharacterized LOC119848591, transcript variant X2
uncharacterized LOC119848591, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
solute carrier family 4 member 5, transcript variant X9
solute carrier family 4 member 5, transcript variant X4
solute carrier family 4 member 5, transcript variant X2
solute carrier family 4 member 5, transcript variant X5
solute carrier family 4 member 5, transcript variant X1
solute carrier family 4 member 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 4 member 5, transcript variant X3
solute carrier family 4 member 5, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 4 isoform X1
electrogenic sodium bicarbonate cotransporter 4 isoform X9
electrogenic sodium bicarbonate cotransporter 4 isoform X4
electrogenic sodium bicarbonate cotransporter 4 isoform X2
electrogenic sodium bicarbonate cotransporter 4 isoform X5
electrogenic sodium bicarbonate cotransporter 4 isoform X6
electrogenic sodium bicarbonate cotransporter 4 isoform X3
electrogenic sodium bicarbonate cotransporter 4 isoform X7
solute carrier family 4 member 5, transcript variant X8
electrogenic sodium bicarbonate cotransporter 4 isoform X8
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial
LOW QUALITY PROTEIN: MOB kinase activator 1A
LOW QUALITY PROTEIN: bolA-like protein 3
tet methylcytosine dioxygenase 3, transcript variant X3
tet methylcytosine dioxygenase 3, transcript variant X1
tet methylcytosine dioxygenase 3, transcript variant X2
tet methylcytosine dioxygenase 3, transcript variant X4
tet methylcytosine dioxygenase 3, transcript variant X7
tet methylcytosine dioxygenase 3, transcript variant X6
tet methylcytosine dioxygenase 3, transcript variant X5
methylcytosine dioxygenase TET3 isoform X1
methylcytosine dioxygenase TET3 isoform X2
methylcytosine dioxygenase TET3 isoform X3
deoxyguanosine kinase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
deoxyguanosine kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
deoxyguanosine kinase, transcript variant X1
deoxyguanosine kinase, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
deoxyguanosine kinase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
deoxyguanosine kinase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
deoxyguanosine kinase, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
deoxyguanosine kinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 long SRA reads, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
deoxyguanosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
deoxyguanosine kinase, mitochondrial isoform X3
deoxyguanosine kinase, mitochondrial isoform X2
deoxyguanosine kinase, mitochondrial isoform X1
deoxyguanosine kinase, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 22 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
deoxyguanosine kinase, mitochondrial isoform X4
STAM binding protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
STAM binding protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
STAM binding protein, transcript variant X1
STAM binding protein, transcript variant X5
STAM binding protein, transcript variant X2
STAM binding protein, transcript variant X4
STAM binding protein, transcript variant X3
RNA/RNP complex-1-interacting phosphatase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein C2orf78 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel interacting protein 3, transcript variant X1
potassium voltage-gated channel interacting protein 3, transcript variant X2
potassium voltage-gated channel interacting protein 3, transcript variant X3
potassium voltage-gated channel interacting protein 3, transcript variant X4
fumarylacetoacetate hydrolase domain-containing protein 2-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: fumarylacetoacetate hydrolase domain-containing protein 2-like
glycerol-3-phosphate acyltransferase 2, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glycerol-3-phosphate acyltransferase 2, mitochondrial, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glycerol-3-phosphate acyltransferase 2, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glycerol-3-phosphate acyltransferase 2, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glycerol-3-phosphate acyltransferase 2, mitochondrial isoform X2
glycerol-3-phosphate acyltransferase 2, mitochondrial isoform X3
glycerol-3-phosphate acyltransferase 2, mitochondrial isoform X1
glycerol-3-phosphate acyltransferase 2, mitochondrial isoform X4
ELMO domain containing 3, transcript variant X2
ELMO domain containing 3, transcript variant X1
ELMO domain-containing protein 3 isoform X2
ELMO domain-containing protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92 long SRA reads, 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
all-trans-retinol 13,14-reductase isoform X1
all-trans-retinol 13,14-reductase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
trans-golgi network protein 2, transcript variant X9
trans-golgi network protein 2, transcript variant X3
trans-golgi network protein 2, transcript variant X7
trans-golgi network protein 2, transcript variant X5
trans-golgi network protein 2, transcript variant X6
trans-golgi network protein 2, transcript variant X8
trans-golgi network protein 2, transcript variant X4
trans-golgi network protein 2, transcript variant X1
trans-golgi network protein 2, transcript variant X2
trans-Golgi network integral membrane protein 2 isoform X2
trans-Golgi network integral membrane protein 2 isoform X9
trans-Golgi network integral membrane protein 2 isoform X3
trans-Golgi network integral membrane protein 2 isoform X7
trans-Golgi network integral membrane protein 2 isoform X5
trans-Golgi network integral membrane protein 2 isoform X6
trans-Golgi network integral membrane protein 2 isoform X8
trans-Golgi network integral membrane protein 2 isoform X4
trans-Golgi network integral membrane protein 2 isoform X1
transcription factor 7 like 1, transcript variant X2
transcription factor 7 like 1, transcript variant X1
transcription factor 7 like 1, transcript variant X3
transcription factor 7-like 1 isoform X2
transcription factor 7-like 1 isoform X1
transcription factor 7-like 1 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
matrix metalloproteinase-17-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
matrix metalloproteinase-17-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: adipocyte enhancer-binding protein 1
DNA polymerase delta 2, accessory subunit
pulmonary surfactant-associated protein B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
myosin regulatory light chain 2, atrial isoform
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
YKT6 v-SNARE homolog, transcript variant X2
YKT6 v-SNARE homolog, transcript variant X4
YKT6 v-SNARE homolog, transcript variant X3
YKT6 v-SNARE homolog, transcript variant X1
calcium/calmodulin dependent protein kinase II beta, transcript variant X3
calcium/calmodulin dependent protein kinase II beta, transcript variant X6
calcium/calmodulin dependent protein kinase II beta, transcript variant X9
calcium/calmodulin dependent protein kinase II beta, transcript variant X7
calcium/calmodulin dependent protein kinase II beta, transcript variant X4
calcium/calmodulin dependent protein kinase II beta, transcript variant X1
calcium/calmodulin dependent protein kinase II beta, transcript variant X8
calcium/calmodulin dependent protein kinase II beta, transcript variant X5
calcium/calmodulin dependent protein kinase II beta, transcript variant X2
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X9
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X7
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X6
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X3
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X4
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X8
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X5
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X2
astacin like metalloendopeptidase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
astacin like metalloendopeptidase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 172 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
astacin like metalloendopeptidase, transcript variant X2
astacin-like metalloendopeptidase isoform X2
astacin-like metalloendopeptidase isoform X1
StAR related lipid transfer domain containing 7, transcript variant X1
StAR related lipid transfer domain containing 7, transcript variant X2
stAR-related lipid transfer protein 7, mitochondrial isoform X1
stAR-related lipid transfer protein 7, mitochondrial isoform X2
cytosolic iron-sulfur assembly component 1, transcript variant X2
cytosolic iron-sulfur assembly component 1, transcript variant X1
probable cytosolic iron-sulfur protein assembly protein CIAO1 isoform X1
probable cytosolic iron-sulfur protein assembly protein CIAO1 isoform X2
small nuclear ribonucleoprotein U5 subunit 200
U5 small nuclear ribonucleoprotein 200 kDa helicase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
inositol 1,4,5-trisphosphate receptor-interacting protein-like 1
non-SMC condensin I complex subunit H, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
non-SMC condensin I complex subunit H, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
neuralized E3 ubiquitin protein ligase 3, transcript variant X2
neuralized E3 ubiquitin protein ligase 3, transcript variant X1
E3 ubiquitin-protein ligase NEURL3 isoform X2
E3 ubiquitin-protein ligase NEURL3 isoform X1
KAT8 regulatory NSL complex subunit 3, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3 isoform X12
AT-rich interaction domain 5A, transcript variant X3
AT-rich interactive domain-containing protein 5A isoform X3
AT-rich interaction domain 5A, transcript variant X2
AT-rich interactive domain-containing protein 5A isoform X2
AT-rich interaction domain 5A, transcript variant X1
AT-rich interactive domain-containing protein 5A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 60% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3 isoform X9
KAT8 regulatory NSL complex subunit 3 isoform X4
KAT8 regulatory NSL complex subunit 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3 isoform X8
KAT8 regulatory NSL complex subunit 3, transcript variant X17
KAT8 regulatory NSL complex subunit 3, transcript variant X12
KAT8 regulatory NSL complex subunit 3, transcript variant X3
KAT8 regulatory NSL complex subunit 3, transcript variant X16
KAT8 regulatory NSL complex subunit 3, transcript variant X4
KAT8 regulatory NSL complex subunit 3, transcript variant X1
KAT8 regulatory NSL complex subunit 3, transcript variant X2
KAT8 regulatory NSL complex subunit 3 isoform X2
KAT8 regulatory NSL complex subunit 3 isoform X1
KAT8 regulatory NSL complex subunit 3 isoform X3
KAT8 regulatory NSL complex subunit 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3 isoform X15
KAT8 regulatory NSL complex subunit 3 isoform X10
KAT8 regulatory NSL complex subunit 3 isoform X14
KAT8 regulatory NSL complex subunit 3 isoform X7
KAT8 regulatory NSL complex subunit 3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3 isoform X5
KAT8 regulatory NSL complex subunit 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3 isoform X6
KAT8 regulatory NSL complex subunit 3, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3 isoform X13
KAT8 regulatory NSL complex subunit 3, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3 isoform X11
LOW QUALITY PROTEIN: fer-1-like protein 5
lectin, mannose binding 2 like, transcript variant X2
lectin, mannose binding 2 like, transcript variant X1
cyclin and CBS domain divalent metal cation transport mediator 4
LOW QUALITY PROTEIN: metal transporter CNNM4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 54% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: metal transporter CNNM3-like
ankyrin repeat domain 23, transcript variant X2
ankyrin repeat domain 23, transcript variant X1
ankyrin repeat domain-containing protein 23 isoform X2
ankyrin repeat domain-containing protein 23 isoform X1
ankyrin repeat domain-containing protein 39
cytochrome c oxidase subunit 5B, mitochondrial
E3 ubiquitin-protein ligase MARCHF5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcriptional activator protein Pur-beta
heparan sulfate glucosamine 3-O-sulfotransferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
DNA polymerase mu, transcript variant X3
DNA polymerase mu, transcript variant X4
DNA polymerase mu, transcript variant X1
DNA polymerase mu, transcript variant X2
DNA-directed DNA/RNA polymerase mu isoform X2
DNA-directed DNA/RNA polymerase mu isoform X1
DNA-directed DNA/RNA polymerase mu isoform X4
DNA-directed DNA/RNA polymerase mu isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: vesicle-associated membrane protein 8
ring finger protein 181, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
ring finger protein 181, transcript variant X2
E3 ubiquitin-protein ligase RNF181 isoform X1
E3 ubiquitin-protein ligase RNF181 isoform X2
transmembrane protein 150A, transcript variant X2
transmembrane protein 150A, transcript variant X1
transmembrane protein 150A, transcript variant X4
transmembrane protein 150A, transcript variant X3
LOW QUALITY PROTEIN: UPF0561 protein C2orf68 homolog
pulmonary surfactant-associated protein B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: PH and SEC7 domain-containing protein 4
interleukin-36 receptor antagonist protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
interleukin-36 receptor antagonist protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
interleukin-36 receptor antagonist protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
interleukin-36 receptor antagonist protein-like
interleukin-1 receptor antagonist protein-like, transcript variant X3
interleukin-1 receptor antagonist protein-like, transcript variant X4
interleukin-1 receptor antagonist protein-like, transcript variant X2
interleukin-1 receptor antagonist protein-like, transcript variant X1
interleukin-36 receptor antagonist protein-like isoform X2
interleukin-36 receptor antagonist protein-like isoform X1
interleukin-1 receptor antagonist protein-like isoform X3
transmembrane emp24 domain-containing protein 4
DEAD-box helicase 56, transcript variant X2
DEAD-box helicase 56, transcript variant X1
probable ATP-dependent RNA helicase DDX56 isoform X2
probable ATP-dependent RNA helicase DDX56 isoform X1
NPC1 like intracellular cholesterol transporter 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
NPC1-like intracellular cholesterol transporter 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
mitochondrial ribosomal protein S24, transcript variant X2
28S ribosomal protein S24, mitochondrial isoform X2
mitochondrial ribosomal protein S24, transcript variant X1
mitochondrial ribosomal protein S24, transcript variant X3
28S ribosomal protein S24, mitochondrial isoform X3
28S ribosomal protein S24, mitochondrial isoform X1
solute carrier family 20 member 1, transcript variant X1
solute carrier family 20 member 1, transcript variant X2
sodium-dependent phosphate transporter 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
cytoskeleton associated protein 2 like, transcript variant X1
cytoskeleton associated protein 2 like, transcript variant X2
cytoskeleton-associated protein 2-like isoform X1
cytoskeleton-associated protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
oxoglutarate dehydrogenase, transcript variant X5
oxoglutarate dehydrogenase, transcript variant X2
oxoglutarate dehydrogenase, transcript variant X4
oxoglutarate dehydrogenase, transcript variant X1
oxoglutarate dehydrogenase, transcript variant X3
2-oxoglutarate dehydrogenase, mitochondrial isoform X2
2-oxoglutarate dehydrogenase, mitochondrial isoform X4
2-oxoglutarate dehydrogenase, mitochondrial isoform X1
2-oxoglutarate dehydrogenase, mitochondrial isoform X5
2-oxoglutarate dehydrogenase, mitochondrial isoform X3
oxoglutarate dehydrogenase, transcript variant X6
oxoglutarate dehydrogenase, transcript variant X7
2-oxoglutarate dehydrogenase, mitochondrial isoform X6
2-oxoglutarate dehydrogenase, mitochondrial isoform X7
oxoglutarate dehydrogenase, transcript variant X8
2-oxoglutarate dehydrogenase, mitochondrial isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments